First-line cisplatin, docetaxel, and cetuximab for patients with recurrent or metastatic head and neck cancer: A multicenter cohort study

BACKGROUND: The targeted therapy cetuximab [directed at the epidermal growth factor receptor (EGFR)] in combination with 5-fluorouracil and platinum-based chemotherapy (the EXTREME regimen) has shown substantial efficacy for patients with recurrent or metastatic squamous cell carcinoma of the head a...

Descripción completa

Detalles Bibliográficos
Autores principales: Falco, Agustín, Leiva, Mariano, Blanco, Albano, Cefarelli, Guido, Rodriguez, Andrés, Melo, Juan, Cayol, Federico, Rizzo, Manglio Miguel, Sola, Alejandro, Rodríguez Montani, Hernán, Chacon, Matías, Enrico, Diego, Waisberg, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894270/
https://www.ncbi.nlm.nih.gov/pubmed/35316930
http://dx.doi.org/10.5306/wjco.v13.i2.147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894270/
https://www.ncbi.nlm.nih.gov/pubmed/35316930
http://dx.doi.org/10.5306/wjco.v13.i2.147

Ejemplares similares